Support for linkage of familial combined hyperlipidemia to chromosome 1q21-q23 in Chinese and German families

Clinical Genetics

Volumn 57, Issue 1, 2000, Pages 29-34

  Pei, Weidong ^d   Baron, Heike ^d   Müller Myhsok, Bertram ^d   Knoblauch, Hans ^d   Al Yahyaee, Said Ali ^a   Hui, Rutai ^a   Wu, Xigui ^a   Liu, Lisheng ^a   Busjahn, Andreas ^d   Luft, Friedrich C ^c   Schuster, Herbert ^b  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b INFOGEN Medizinische Genetik GmbH   (Germany)

^c FRANZ VOLHARD CLINIC   (Germany)

^d NONE

Author keywords

Chromosome 1q; Familial combined hyperlipidemia; Retinoid X receptor

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RETINOID X RECEPTOR; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHINESE; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 1Q; CONTROLLED STUDY; FAMILIAL HYPERLIPEMIA; FEMALE; GENE LOCUS; GENETIC HETEROGENEITY; GENETIC LINKAGE; GERMANY; HUMAN; HUMAN CELL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CHINA; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; FEMALE; GENETIC MARKERS; GERMANY; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; LINKAGE (GENETICS); LOD SCORE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; TRANSCRIPTION FACTORS;

EID: 0033984185     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2000.570105.x     Document Type: Article

References (39)

1. Genest JJ Jr. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 1992: 85: 2025-2033.
2. Grundy SM, Chait J, Brunzell JD. Familial combined hyperlipidemia workshop. Arteriosclerosis 1987: 7: 203-207.
3. Nikkilä EA, Aro A. Family study of serum lipids and lipoproteins in coronary heart disease. Lancet 1973: 1: 954-959.
4. Goldstein JL, Schrott HG, Hazard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary artery disease II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973: 52: 1544-1568.
5. Sniderman A, Shapiro S, Marpole D, Skinner B, Teng B, Kwiterovitch PO Jr. Association of coronary atherosclerosis with hyperapobetalipoproteinemia. Proc Natl Acad Sci USA 1980: 77: 604-688.
6. Austin MA. Plasma triglyceride as a risk factor for coronary heart disease: the epidemiologic evidence and beyond. Am J Epidemiol 1989: 129: 249-259.
7. Williams RR, Hunt SC, Hopkins PN et al. Familial dyslipidemic hypertension: evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA 1988: 259: 3579-3586.
8. Pajukanta P, Nuotio I, Terwilliger JD et al. Linkage of familial combined hyperlipidemia to chromosome Iq21-q23. Nat Genet 1998: 18: 369-373.
9. Knoblauch H, Busjahn A, Müller-Myhsok B et al. Peroxisome proliferator activaed protein γ gene locus, body mass index and lipid values in normal subjects. Arterioscler Thromb Vasc Biol 1999 (in press).
10. Baron H, Fong S, Aydin A, Bähring S, Luft FC, Schuster H. A novel oligonucleotide ligation assay for the diagnosis of familial hypercholesterolemia. Nat Biotechnol 1996: 14: 1279-1282.
11. Schuster H, Lamprecht A, Junghans C et al. Approaches to the genetics of cardiovascular disease through genetic field working. Kidney Int 1998: 53: 1449-1454.
12. Friedewald WT, Levy RI, Fredrickson DS, Friedewald formula: estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of preparative ultracentrifugation. Clin Chem 1972: 18: 499-502.
13. Knoblauch H, Busjahn A, MŸnter S et al. Heritability analysis of lipids and three gene loci in twins link the macrophage scavenger receptor to high-density lipoprotein cholesterol concentrations. Arterioscler Thromb Vasc Biol 1997: 17: 2054-2060.
14. Kruglyak L, Daly MJ, Reeve Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996: 58: 1347-1363.
15. Lange K, Weeks DE. Efficient computation of lod scores: genotype elimination, genotype redefinition, and hybrid maximum likelihood algorithms. Ann Hum Genet 1989: 53: 67-83.
16. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993: 52: 506-516.
17. Sham PC, Curtis D. An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Ann Hum Genet 1995: 59: 323-336.
18. Leal SM, Ott J. A bootstrap approach to estimating power for linkage heterogeneity. Genet Epidemiol 1993: 10: 465-470.
19. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995: 11: 217-241.
20. Risch N, Giuffra L. Model misspecification and multipoint linkage analysis. Hum Hered 1992: 42: 77-92.
21. Dockx P, Decree J, Degreef H. Inhibition of the metabolism of endogenous retinoic acid as a treatment for severe psoriasis: an open study with oral liarozole. Br J Dermatol 1995: 1333: 426-432.
22. Moriwaki H, Blaner WS, Piantedosi R, Goodman DS. Effects of dietary retinoid and triglyceride on the lipid composition of rat liver stellate cells and stellate cell lipid droplets. J Lipid Res 1988: 29: 1523-1534.
23. Standeven AM, Beard RL, Johnson AT et al. Retinoid-induced hypertriglyceridemia in rats is mediated by retinoic acid receptors. Fundam Appl Toxicol 1996: 33: 264-271.
24. Kastner P, Mark M, Leid M et al. Abnormal spermatogenesis in RXR beta mutant mice. Genes Dev 1996: 10: 80-92.
25. Mukherjee R, Strasser J, Jow L, Hoener P, Paterniti JR Jr, Heyman RA. RXR agonists activate PPARalpha-inducible genes, lower triglycerides, and raise HDL levels in vivo. Arterioscler Thromb Vasc Biol 1998: 18: 272-276.
26. Cullen P, Farren B, Scott J, Farrall M. Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia. Arterioscler Thromb 1994: 14: 1233-1249.
27. Jarvik GP, Brunzell JD, Austin MA, Krauss RM, Motulsky AG, Wijsman E. Genetic predictors of FCHL in four large pedigrees. Influence of apo B level major locus predicted genotype and LDL subclass phenotype. Arterioscler Throm 1994: 14: 1687-1694.
28. Austin MA, Brunzell JD, Fitch WL, Krauss RM. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis 1989: 9: 335-344.
29. Nishina PM, Johnson JP, Naggert JK, Krauss RM. Linkage of atherogenic lipoprotein phenotype to me low density lipoprotein receptor locus on the short arm of chromosome 19. Proc Natl Acad Sci USA 1992: 89: 708-712.
30. Wojciechowski AP, Farrall M, Cullen P et al. Familial combined hyperlipidemia linked to the apolipoprotein AI-CIII-AIV gene cluster on chromosome 11q23-q24. Nature 1991: 349: 161-164.
31. Dallinga-Thie GM, van Linde Sibenius Trip M, Rotter JI et al. Complex genetic contribution of the apo AI-CII-AIV gene cluster to familial combined hyperlipidemia. J Clin Invest 1997: 99: 953-961.
32. Marcil M, Boucher B, Gagne E, Davignon J, Hayden M, Genest J Jr. Lack of association of the apolipoprotein AI-CIII-AIV gene Xmni and Sstl polymorphisms and the lipoprotein lipase mutations in familial combined hyperlipoproteinemia in French Canadian subjects. J Lipid Res 1996: 37: 309-319.
33. Kwiterovitch PO Jr. Genetics and molecular biology of familial combined hyperlipidemia. Curr Opin Lipidol 1993: 4: 133-143.
34. Reymer PW, Groenemeyer BE, Gagne E et al. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Hum Mol Genet 1995: 4: 1543-1549.
35. Pajukanta P, Porkka KV, Antikainen M et al. No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families. Arterioscler Thromb Vasc Biol 1997: 17: 841-850.
36. Pajukanta P, Terwilliger JD. Perola M et al. Genomewide scan for familial combined hyperlipidemia genes in Finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels. Ann J Hum Genet 1999: 64: 1453-1463.
37. Paigen B, Mitchell D, Reue K, Morrow A, Lusis AJ, LeBoeuf RC. Ath1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc Natl Acad Sci USA 1987: 87: 3763-3767.
38. Castellani LW, Weinreb A, Bodnar J et al. Mapping a gene for combined hyperlipidemia in a mutant mouse strain. Nat Genet 1998: 18: 374-377.
39. Valera A, Pelegrin M, Asins G et al. Overexpression of mitochondrial 2-hydroxy-3-methylglutaryl-CoA synthase in transgenic mice causes hepatic hyperketogenesis. J Biol Chem 1994: 269: 6267-6270.